Alexandra Bause is a biotech investor, company builder, and thought leader dedicated to translating longevity science into real-world medical interventions. As Co-Founder and Venture Partner at Apollo Health Ventures, one of the world’s leading longevity-focused VC funds, she specializes in identifying breakthrough aging research and building biotech companies that develop therapeutic interventions targeting the biology of aging.
Her PhD studies at Harvard Medical School focused on the molecular mechanisms of aging, providing deep insight into the key pathways driving health and longevity. As a strategy consultant at BCG, she advised top biotech and pharmaceutical companies on portfolio management, R&D strategy, and commercialization.
Through Apollo, she has played a key role in shaping the longevity biotech landscape, funding and incubating companies developing novel therapeutics to address aging at its root cause. Committed to moving longevity beyond hype, she advocates for a science-backed, evidence-based approach that ensures new interventions achieve clinical validation and regulatory approval.
